<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate the role of <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase (GST) and matrix metalloproteinase-9 (MMP-9) expressions in the development and progression of reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo>-Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence in the esophagus </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: GST and MMP-9 expressions were analyzed in 51 paraffin-embedded tissue samples by immunohistochemistry including patients with reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (n = 7), Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> (n = 14), Barrett and <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (n = 8), Barrett and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 7), esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 8) and a control group without any histological changes (n = 7) </plain></SENT>
<SENT sid="2" pm="."><plain>Immunostaining was determined semiquantitatively </plain></SENT>
<SENT sid="3" pm="."><plain>Statistical analysis with one-way ANOVA, <z:chebi fb="162" ids="6605">LSD</z:chebi> test and correlation analysis were performed </plain></SENT>
<SENT sid="4" pm="."><plain>P value of &lt; 0.05 was considered significant </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: GST expression was significantly higher while MMP-9 expression was significantly lower in control group compared to Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath> and the other groups </plain></SENT>
<SENT sid="6" pm="."><plain>No major changes were observed between Barrett, <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, and Barrett and concomitant <z:hpo ids='HP_0100633'>esophagitis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Barrett and concomitant <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> revealed a significant lower expression of GST and higher levels of MMP-9 compared to <z:hpo ids='HP_0000001'>all</z:hpo> other groups </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0009308'>Adenocarcinoma</z:mp> showed almost no expression of GST and significantly higher levels of MMP-9 than Barrett and concomitant <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Alterations of GST and MMP-9 were inversely correlated (r = -0.82) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Decreased GST and increased expression of MMP-9 in Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence as compared to <z:mpath ids='MPATH_458'>normal</z:mpath> tissue suggest their association with esophageal <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Loss of GST and gain of MMP-9 in Barrett with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> compared to non-dysplastic <z:mpath ids='MPATH_160'>metaplasia</z:mpath> indicate that these alterations may be early events in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Quantification of these parameters in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> might be useful to identify patients at higher risk for progression to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>